Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights

11.05.2023 - - Combined revenue and government support income increased 199% year-over-year - - Sequential revenue growth of 28% -- Filed 513(g) submission with U.S. FDA for Intelligent Fingerprinting Drug Screening Cartridge - - Granted U.K. patent relating ...

Related Keywords

Australia ,United States ,United Kingdom ,New Zealand ,Cheryl Billson ,Valter Pinto ,Asia Pacific ,Harry Simeonidis ,Business Development ,Company On ,Company Nasdaq ,Strategic Partnerships Pipeline Development ,Exchange Commission ,Strategic Communications ,Securities Exchange ,Company Contact ,University Of Newcastle ,Intelligent Fingerprinting Ltd ,Intelligent Bio Solutions ,Company Intelligent Fingerprinting Drug Screening System ,Drug Administration ,National Association Of Testing Authorities ,Intelligent Bio Solutions Inc ,Comma Communications ,Bio Solutions ,Chief Executive Officer ,Intelligent Bio ,Fingerprinting Drug Screening System ,Plus Cartridge Reader ,Intelligent Fingerprinting ,Intelligent Fingerprinting Drug Screening System ,Dodman Limited ,Boughey Distribution ,United States Food ,Intelligent Fingerprinting Drug ,Planned Events ,Targeted Milestones ,Coming Fiscal ,Intelligent Fingerprinting System ,National Association ,Testing Authorities ,Quarter Ended March ,Drug Screening System ,Looking Statements ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Intelligent Bio Solution ,Consolidated Statements ,Months Ended March ,